BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20160327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20161030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160212
DTEND;VALUE=DATE:20160213
DTSTAMP:20260730T040648
CREATED:20151218T122244Z
LAST-MODIFIED:20160111T145524Z
UID:11948-1455235200-1455321599@ces.b2sg.org
SUMMARY:Grand Challenge Awards- Challenge 2: Eradicate EBV-induced cancers from the world
DESCRIPTION:Around 19 in 20 adults carry the Epstein Barr Virus (EBV)\, making it one of the most common human viral infections. \nIn most people\, EBV is relatively harmless\, although it’s the cause of glandular fever\, “kissing disease”. But in some parts of the world it’s a big problem – every year\, EBV infection accounts for 200\,000 new cases of cancer worldwide\, and more than 140\,000 deaths. \nTo eradicate EBV-induced cancers from the world is a grand challenge that would make a significant difference to global health\, and is a fully achievable ambition.
URL:https://ces.b2sg.org/event/grand-challenge-awards-challenge-2-eradicate-ebv-induced-cancers-from-the-world/
CATEGORIES:Awards
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/Cancer-research-UK1.png
END:VEVENT
END:VCALENDAR